[go: up one dir, main page]

PT2655595T - Bactéria e extratos da referida bactéria e uso dos mesmos em dermatologia - Google Patents

Bactéria e extratos da referida bactéria e uso dos mesmos em dermatologia

Info

Publication number
PT2655595T
PT2655595T PT11802426T PT11802426T PT2655595T PT 2655595 T PT2655595 T PT 2655595T PT 11802426 T PT11802426 T PT 11802426T PT 11802426 T PT11802426 T PT 11802426T PT 2655595 T PT2655595 T PT 2655595T
Authority
PT
Portugal
Prior art keywords
bacterium
dermatology
extracts
same
novel
Prior art date
Application number
PT11802426T
Other languages
English (en)
Inventor
Aries Marie-Françoise
Castex-Rizzi Nathalie
Lebaron Philippe
Bourrain Muriel
Nguyen Thien
Chol Bertrand
Ravard Helffer Katia
Original Assignee
Fabre Pierre Dermo Cosmetique
Univ Pierre Et Marie Curie Paris 6
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44359781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2655595(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fabre Pierre Dermo Cosmetique, Univ Pierre Et Marie Curie Paris 6, Centre Nat Rech Scient filed Critical Fabre Pierre Dermo Cosmetique
Publication of PT2655595T publication Critical patent/PT2655595T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT11802426T 2010-12-22 2011-12-22 Bactéria e extratos da referida bactéria e uso dos mesmos em dermatologia PT2655595T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1061081A FR2969657B1 (fr) 2010-12-22 2010-12-22 Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie

Publications (1)

Publication Number Publication Date
PT2655595T true PT2655595T (pt) 2018-11-02

Family

ID=44359781

Family Applications (1)

Application Number Title Priority Date Filing Date
PT11802426T PT2655595T (pt) 2010-12-22 2011-12-22 Bactéria e extratos da referida bactéria e uso dos mesmos em dermatologia

Country Status (29)

Country Link
US (2) US9084811B2 (pt)
EP (1) EP2655595B1 (pt)
JP (2) JP6117111B2 (pt)
KR (1) KR102043472B1 (pt)
CN (1) CN103403144B (pt)
AR (1) AR084454A1 (pt)
AU (1) AU2011347254B2 (pt)
CA (1) CA2821653C (pt)
CL (1) CL2013001853A1 (pt)
CO (1) CO6741177A2 (pt)
DK (1) DK2655595T3 (pt)
ES (1) ES2689138T3 (pt)
FR (1) FR2969657B1 (pt)
GE (1) GEP201606589B (pt)
IL (1) IL226943B (pt)
MA (1) MA34734B1 (pt)
MX (1) MX345125B (pt)
MY (1) MY173066A (pt)
NZ (1) NZ612294A (pt)
PH (1) PH12013501267A1 (pt)
PL (1) PL2655595T3 (pt)
PT (1) PT2655595T (pt)
RU (1) RU2612790C2 (pt)
SG (1) SG191236A1 (pt)
TN (1) TN2013000249A1 (pt)
TW (1) TW201307551A (pt)
UA (1) UA113399C2 (pt)
WO (1) WO2012085182A1 (pt)
ZA (1) ZA201304355B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013190106A1 (en) * 2012-06-21 2013-12-27 Pierre Fabre Medicament Use of a live bacterium for the treatment of intestinal inflammatory disorders
WO2015048245A1 (en) 2013-09-25 2015-04-02 Vertex Pharmaceuticals Incorporated Imidazopyridazines useful as inhibitors of the par-2 signaling pathway
FR3065009B1 (fr) * 2017-04-06 2020-11-27 Fabre Pierre Dermo Cosmetique Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
FR3081705B1 (fr) 2018-06-01 2020-12-04 Fabre Pierre Dermo Cosmetique Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
FR3114024B1 (fr) 2020-09-11 2022-09-09 Fabre Pierre Dermo Cosmetique Nouvelle émulsion mimant la peau
JP7698983B2 (ja) * 2021-06-02 2025-06-26 花王株式会社 腸管感染症の予防又は改善剤
JP7695824B2 (ja) * 2021-06-02 2025-06-19 花王株式会社 皮膚細菌感染症の予防又は改善剤
WO2024218205A1 (en) * 2023-04-18 2024-10-24 Pierre Fabre Dermo-Cosmetique Novel bacterial strain useful for treating cutaneous inflammation
FR3150712A1 (fr) 2023-07-06 2025-01-10 Pierre Fabre Dermo-Cosmetique Composition pour le traitement de désordres inflammatoires cutanés
FR3149774B1 (fr) 2024-01-11 2025-06-20 Fabre Pierre Dermo Cosmetique 5,6,5’,6’-tétraphényl-3,3’-(1,4-phénylène)-bis[1,2,4]triazine pour améliorer l’aspect des cicatrices et/ou réduire les marques cicatricielles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69019956T2 (de) * 1989-10-06 1995-11-23 Janos Szabo Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung.
CH680045A5 (pt) * 1990-02-16 1992-06-15 Om Lab Sa
BR9608500A (pt) * 1995-09-07 1999-07-06 Oreal Utilização de pelo menos um extrato de pelo menos uma bactéria filamentosa não fotossintética composição cosmética ou farmacêutica e processo de tratamento cosméstico
US7807181B2 (en) * 2002-03-20 2010-10-05 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
GB0321615D0 (en) * 2003-09-15 2003-10-15 Glaxo Group Ltd Improvements in vaccination
US20050163764A1 (en) * 2003-09-22 2005-07-28 Yale University Treatment with agonists of toll-like receptors
US7244607B2 (en) * 2003-10-01 2007-07-17 The United States Of America, As Represented By The Secretary Of Agriculture Chromobacterium subtsugae sp. nov. for control of insect pests
EP3332791A1 (en) * 2007-03-05 2018-06-13 OM Pharma Bacterial extract for respiratory disorders and process for its preparation
FR2918884B1 (fr) * 2007-07-17 2010-01-15 Oreal Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur
FR2918883B1 (fr) * 2007-07-17 2010-01-15 Oreal Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
FR2918885B1 (fr) * 2007-07-17 2009-08-28 Oreal Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
CA2722558A1 (en) * 2008-04-25 2009-10-29 Id Biomedical Corporation Of Quebec Methods for preparing immunogenic compositions
CN102046198A (zh) 2008-04-25 2011-05-04 系统生物学研究所 鞭毛蛋白多肽疫苗
SI22889A (sl) 2008-10-28 2010-04-30 Kemijski inštitut Himerni flagelini za cepiva
WO2010135704A2 (en) 2009-05-22 2010-11-25 Institute For Systems Biology Secretion-related bacterial proteins for nlrc4 stimulation
KR101762610B1 (ko) * 2010-11-05 2017-08-04 삼성전자주식회사 이동 통신 시스템에서 역방향 스케줄링 및 그를 위한 정보 전송 방법 및 장치

Also Published As

Publication number Publication date
JP6117111B2 (ja) 2017-04-19
US9662357B2 (en) 2017-05-30
CN103403144B (zh) 2015-11-25
BR112013015998A2 (pt) 2017-04-11
FR2969657A1 (fr) 2012-06-29
MX345125B (es) 2017-01-17
IL226943B (en) 2019-02-28
CO6741177A2 (es) 2013-08-30
HK1187366A1 (zh) 2014-04-04
EP2655595B1 (en) 2018-07-04
RU2612790C2 (ru) 2017-03-13
CA2821653C (en) 2020-03-10
ZA201304355B (en) 2014-11-26
RU2013132895A (ru) 2015-01-27
GEP201606589B (en) 2017-01-10
US20150231187A1 (en) 2015-08-20
NZ612294A (en) 2015-05-29
UA113399C2 (xx) 2017-01-25
WO2012085182A1 (en) 2012-06-28
CA2821653A1 (en) 2012-06-28
PH12013501267A1 (en) 2013-08-28
CL2013001853A1 (es) 2014-03-28
PL2655595T3 (pl) 2019-07-31
KR102043472B1 (ko) 2019-11-11
MX2013007217A (es) 2014-01-08
EP2655595A1 (en) 2013-10-30
FR2969657B1 (fr) 2014-02-07
AR084454A1 (es) 2013-05-15
SG191236A1 (en) 2013-07-31
TW201307551A (zh) 2013-02-16
US9084811B2 (en) 2015-07-21
US20130316033A1 (en) 2013-11-28
CN103403144A (zh) 2013-11-20
ES2689138T3 (es) 2018-11-08
AU2011347254A1 (en) 2013-07-11
TN2013000249A1 (en) 2014-11-10
MA34734B1 (fr) 2013-12-03
JP2014503211A (ja) 2014-02-13
MY173066A (en) 2019-12-23
AU2011347254B2 (en) 2016-07-14
DK2655595T3 (en) 2018-10-08
JP2017099393A (ja) 2017-06-08
KR20140030109A (ko) 2014-03-11

Similar Documents

Publication Publication Date Title
PL2655595T3 (pl) Nowa bakteria i ekstrakty ze wspomnianej bakterii oraz ich zastosowanie w dermatologii
IL249669A0 (en) Converted 5-fluoro-1h-pyrazolopyridines and their use
IL221511A (en) Arilatriazolones associated with bis aryl and their use
PL2606120T3 (pl) Ludzkie komórki ułatwiające tolerancję i ich zastosowanie
ZA201208173B (en) Peptices and their use
HUE047179T2 (hu) Szilícium-dioxid részecskék és az ezeket tartalmazó fogápoló készítmény
EP2552953A4 (en) FRIZZLED-BINDING SUBSTANCES AND ITS USES
ZA201305076B (en) Substituted 1-benzylccloalkycarboxlic acids and use thereof
PL2469142T3 (pl) Złączka zaciskowa i jej zastosowanie
PL2605757T3 (pl) Preparaty oparte na nalbufinie i ich zastosowania
EP2697378A4 (en) IDENTIFICATION AND USE OF KRP MUTANTS IN PLANTS
PT2521445T (pt) Formulação e utilização da mesma
GB2480515B (en) Lacquer composition and use thereof
ZA201302854B (en) Substituted benzamides and their uses
SI2552440T1 (sl) Nove kombinacije in uporaba
PT2563806E (pt) Leucolectinas humanas e suas utilizações
ZA201302335B (en) Susbtituted n-phenethyltriazoloneacetamides and use thereof
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy
GB201006479D0 (en) Garment and use thereof
WO2012040456A3 (en) Human b1 cells and uses thereof
IL217137A0 (en) Medicinal and herbal composition and uses thereof
EP2657236A4 (en) NEW 2-ALKYNYL-N9-PROPARGYLADENINE AND ITS MEDICAL USE
EP2616088A4 (en) FUNGAL EXTRACTS AND USES THEREOF
AU2009902835A0 (en) Cosmetic methods and devices
AU2010904801A0 (en) Seleno-Compounds and Therapeutic Uses Thereof